10 TIMED ARTIFICIAL INSEMINATION PROTOCOLS TO SYNCHRONIZATION OF OVULATION IN BOS TAURUS TAURUS SUCKLING BEEF COWS

Abstract

The aim of this study was to compare 3 methods for synchronization of ovulation in anestrous beef cows. The hypothesis of this study was to determine whether low doses of hCG has superior efficacy to cypionate to induce ovulation in anestrous cows and provide higher pregnancy rate in oestrus-synchronization programs. Synchronization of ovulation and conception rate to timed AI (TAI) were evaluated in anestrus Bos taurus taurus suckling beef cows 45 ± 15 days postpartum and with body condition score of 2.9 (1 to 5) maintained in a native pastured system in the south of Brazil. Females were evaluated with ultrasound on the Day 0 (D0) of the protocol (Day 0), day 8 (D8), immediately before TAI (D10), and 7 days after TAI (Day 17). All cows were synchronized with an intravaginal progesterone-releasing device (IPRD; 0.75 g of progesterone, Prociclar®, Hertape Calier Animal Health, Juatuba, Brazil) and 2 mg IM of oestradiol benzoate (EB; Benzoato HC®) on D0. On Day 8, the IPRD was removed and 150 μg of D (+) cloprostenol (Veteglan Luteolytic®), and 25 IU IM FSH/LH (Pluset®) were administered. Females of the EC (n = 84) group received 1 mg IM of oestradiol cypionate (EC; Cipionato HC®). Females on D8 of the hCG (n = 81) group received 500 IU IM of hCG (Vetecor®, Hertape Calier) at the time of TAI. The females of the EC + hCG group (n = 83) received both treatments. All cows were submitted to TAI 54 h after withdrawal of IPRD. A part of the cows (n = 102) had the ovulation evaluated every 12 h from the withdrawal of IPRD [EC (n = 34), hCG (n = 34), and hCG + EC (n = 33)]. Statistical analysis was performed using SAS PROC GLIMMIX. The dominant follicle diameter (FD) on Day 8 (8.7 ± 0.2, 8.8 ± 0.2, 8.6 ± 0.2) did not differ between treatments EC, EC + hCG, or hCG (P = 0.79). However, the FD on D10 was higher (P = 0.001) for cows treated with hCG (12.9 ± 0.3) compared with cows from the EC (11.3 ± 0.2) or EC + hCG group (11.8 ± 0.2). The interval (h) between the withdrawal of IPRD and ovulation was lower (P = 0.01) for the hCG group, (71.2 ± 1.7) compared with the groups treated with EC or EC + hCG (76.6 ± 2.18 and 74.2 ± 1.65), respectively. The ovulation rate did not differ (P = 0.61) among the EC (85.2%, 29/34), hCG (91.1%, 31/34), or EC + hCG groups (90.9%, 30/33). Corpus luteum diameter (mm) was higher (P = 0.04) on D17 for the hCG-treated group (21.4 ± 0.3) compared with others treatments (EC = 19.1 ± 0.8 or EC + hCG = 20.4 ± 0.8). However, the plasma progesterone levels on D17 were EC = 2.0 ± 0.1, hCG = 2.4 ± 0.1, and EC + hCG = 2.3 ± 0.1 ng mL–1 (P = 0.19), and the conception rate on the 28th day after TAI (EC = 43.0%; hCG = 47.0%, and EC + hCG = 48.8%; P = 0.76) was also similar. The hCG determined smallest ovulation interval, but similar rates of pregnancy were observed with both treatments.